# PCOS Treatment Using DLBS3233, Metformin, and Combination of Both

> **NCT01999686** · PHASE3 · COMPLETED · sponsor: **Dexa Medica Group** · enrollment: 186 (actual)

## Conditions studied

- Polycystic Ovary Syndrome (PCOS)
- Insulin Resistance

## Interventions

- **DRUG:** DLBS3233
- **DRUG:** Metformin XR
- **DRUG:** Placebo metformin
- **DRUG:** Placebo DLBS3233

## Key facts

- **NCT ID:** NCT01999686
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2019-02
- **Final completion:** 2019-05
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2019-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01999686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01999686, "PCOS Treatment Using DLBS3233, Metformin, and Combination of Both". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01999686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*